CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+11.29%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$2.27B
AUM Growth
+$2.27B
(-0.36%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-5.36%
Top 10 Holdings %
Top 10 Hldgs %
41.58%
Holding
96
New
16
Increased
10
Reduced
55
Closed
6
Top Buys
| 1 |
Immunovant
IMVT
|
$57.6M |
| 2 |
ALX Oncology
ALXO
|
$36M |
| 3 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$35.5M |
| 4 |
Zymeworks
ZYME
|
$27.9M |
| 5 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$23.4M |
Top Sells
Sector Composition
| 1 | Healthcare | 91.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rocket Pharmaceuticals
RCKT
$354M
| $31.3M | 1.2% | 1,368,550 -100,000 | -7% | -$2.29M |
|
27
Arcturus Therapeutics
ARCT
$462M
| $30M | 1.15% | 700,000 -100,000 | -13% | -$4.29M |
|
|
MYOV
28
DELISTED
Myovant Sciences Ltd.
MYOV
| $30M | 1.15% | 2,134,966 -365,034 | -15% | -$5.13M |
|
29
Akero Therapeutics
AKRO
$3.74B
| $26.5M | 1.02% | 859,550 +267,011 | +45% | +$8.22M |
|
|
BPMC
30
DELISTED
Blueprint Medicines
BPMC
| $25.5M | 0.98% | 275,000 -75,000 | -21% | -$6.95M |
|
31
CRISPR Therapeutics
CRSP
$4.71B
| $25.1M | 0.96% | 300,000 -100,000 | -25% | -$8.36M |
|
|
ALBO
32
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $23.4M | 0.9% | +700,000 | New | +$23.4M |
|
33
BioNTech
BNTX
$24B
| $22.4M | 0.86% | 325,000 +150,000 | +86% | +$10.3M |
|
34
Cabaletta Bio
CABA
$133M
| $22.4M | 0.86% | 2,067,302 -38,542 | -2% | -$418K |
|
35
Beam Therapeutics
BEAM
$1.66B
| $19.6M | 0.75% | 796,428 -1 | -0% | -$25 |
|
36
Ascendis Pharma
ASND
$11.8B
| $19.3M | 0.74% | 125,000 -50,000 | -29% | -$7.72M |
|
37
Galapagos
GLPG
$2.07B
| $18.5M | 0.71% | 130,000 +30,925 | +31% | +$4.39M |
|
38
Axsome Therapeutics
AXSM
$6.05B
| $17.8M | 0.68% | 250,000 -100,000 | -29% | -$7.13M |
|
|
IGMS
39
DELISTED
IGM Biosciences
IGMS
| $16.6M | 0.64% | 225,000 -115,146 | -34% | -$8.5M |
|
40
Zai Lab
ZLAB
$3.68B
| $15.7M | 0.6% | 189,092 -60,908 | -24% | -$5.07M |
|
41
Inspire Medical Systems
INSP
$2.77B
| $15.5M | 0.6% | 120,000 -27,982 | -19% | -$3.61M |
|
42
Kura Oncology
KURA
$686M
| $15.3M | 0.59% | 500,000 -200,000 | -29% | -$6.13M |
|
43
Pliant Therapeutics
PLRX
$101M
| $13.6M | 0.52% | 611,409 | – | – |
|
|
OTIC
44
DELISTED
Otonomy, Inc.
OTIC
| $13.1M | 0.5% | +3,241,800 | New | +$13.1M |
|
|
DCPH
45
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $12.8M | 0.49% | 250,000 -68,914 | -22% | -$3.54M |
|
|
TCRR
46
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $12.2M | 0.47% | +600,000 | New | +$12.2M |
|
47
uniQure
QURE
$896M
| $12M | 0.46% | 325,000 -119,157 | -27% | -$4.39M |
|
48
Sarepta Therapeutics
SRPT
$1.78B
| $11.9M | 0.46% | 85,000 -25,000 | -23% | -$3.51M |
|
49
Insmed
INSM
$28.8B
| $11.2M | 0.43% | 350,000 -100,000 | -22% | -$3.21M |
|
|
AKUS
50
DELISTED
Akouos, Inc. Common Stock
AKUS
| $11.2M | 0.43% | 499,991 +1 | +0% | +$22 |
|